Reps. Earl Blumenauer, D-Ore., and Markwayne Mullin, R-Okla., yesterday reintroduced  the Overdose Prevention and Patient Safety Act (H.R. 2062), AHA-supported legislation that would align 42 CFR Part 2, federal regulations governing the confidentiality of substance use disorder treatment and prevention records, with Health Insurance Portability and Accountability Act regulations, and strengthen patient protections. Sens. Joe Manchin, D-W.Va., and Shelley Moore Capito, R-W.Va., have reintroduced companion legislation (S. 1012), the Protecting Jessica Grubb’s Legacy Act. 

Both the House and Senate bills would prohibit the use of SUD treatment records in criminal, civil or administrative contexts; require providers to provide notice in the event of a breach of unsecured protected health information; and require providers to issue, with guidance from the Health and Human Secretary, easily understandable notices of privacy practices.

In a statement, AHA praised the lawmakers for reintroducing the bill, and said, “Too many patients with substance use disorder have been prescribed an opioid or another drug that may endanger their life or sobriety because of an outdated law that prevents clinicians from reviewing their complete treatment history. The Overdose Prevention and Patient Safety Act and the Protecting Jessica Grubb’s Legacy Act would allow clinicians access to the information they need to ensure patient safety and the highest quality of care.”

The Partnership to Amend 42 CFR Part 2, a coalition of nearly 50 health care organizations including the AHA, also applauded the bipartisan bills. 
 

Related News Articles

Headline
The Department of Health and Human Services’ Office for Civil Rights should finalize its proposed “commonsense” amendments to the HIPAA Privacy Rule to support…
Headline
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be…
Perspective
Yesterday marked the official end of the COVID-19 public health emergency. For more than three years, hospitals, health systems and front-line health care…
Headline
Pregnant people with opioid use disorder are more likely to receive buprenorphine (a recommended treatment) if they are older, white and have public insurance…
Headline
The Department of Health & Human Services’ Office for Civil Rights today released a proposed rule that would prohibit entities regulated by the HIPAA…
Headline
New results from an ongoing clinical trial provide strong evidence that emergency departments can safely start buprenorphine treatment for opioid use disorder…